Meeting NewsVideo

VIDEO: Quarterly dosing beneficial for some AMD patients

HONOLULU — At the Association for Research in Vision and Ophthalmology meeting here, David A. Eichenbaum, MD, discusses how anti-VEGF treatments can be extended to quarterly dosing rather than monthly in patients with neovascular age-related macular degeneration.

HONOLULU — At the Association for Research in Vision and Ophthalmology meeting here, David A. Eichenbaum, MD, discusses how anti-VEGF treatments can be extended to quarterly dosing rather than monthly in patients with neovascular age-related macular degeneration.

    See more from Association for Research in Vision and Ophthalmology